share_log

Encompass Health Analyst Ratings

エンカンパス・ヘルスのアナリスト評価

Benzinga ·  2023/09/28 10:32
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/28/2023 23.79% RBC Capital → $83 Reiterates Outperform → Outperform
08/08/2023 23.79% RBC Capital $70 → $83 Maintains Outperform
08/04/2023 4.4% Barclays $61 → $70 Maintains Equal-Weight
08/04/2023 19.31% Credit Suisse $76 → $80 Maintains Outperform
08/03/2023 26.77% Raymond James $80 → $85 Maintains Strong Buy
08/03/2023 22.3% Truist Securities $75 → $82 Maintains Buy
08/03/2023 14.84% Mizuho $74 → $77 Maintains Buy
08/03/2023 5.89% Barclays $61 → $71 Maintains Equal-Weight
07/20/2023 16.33% Stephens & Co. → $78 Reiterates Overweight → Overweight
06/29/2023 16.33% Stephens & Co. $74 → $78 Maintains Overweight
05/02/2023 4.4% RBC Capital $66 → $70 Maintains Outperform
05/02/2023 19.31% Raymond James $72 → $80 Maintains Strong Buy
05/01/2023 8.87% Deutsche Bank $70 → $73 Maintains Buy
05/01/2023 10.37% Stephens & Co. $70 → $74 Maintains Overweight
05/01/2023 13.35% Credit Suisse $73 → $76 Maintains Outperform
05/01/2023 10.37% Mizuho $69 → $74 Maintains Buy
04/28/2023 10.37% B of A Securities $69 → $74 Maintains Buy
04/04/2023 -9.02% Barclays $57 → $61 Maintains Equal-Weight
03/14/2023 -14.99% Barclays → $57 Initiates Coverage On → Equal-Weight
02/09/2023 11.86% Truist Securities $70 → $75 Maintains Buy
02/09/2023 8.87% Credit Suisse $62 → $73 Maintains Outperform
02/09/2023 2.91% Mizuho $65 → $69 Maintains Buy
02/08/2023 4.4% Stephens & Co. → $70 Maintains Overweight
10/28/2022 -13.5% Stephens & Co. $60 → $58 Maintains Overweight
10/28/2022 7.38% Raymond James $65 → $72 Maintains Strong Buy
09/21/2022 -7.53% Credit Suisse $63 → $62 Maintains Outperform
08/24/2022 -1.57% RBC Capital $82 → $66 Maintains Outperform
08/08/2022 -3.06% Truist Securities $75 → $65 Maintains Buy
08/04/2022 -3.06% BMO Capital $83 → $65 Maintains Outperform
08/04/2022 -3.06% Raymond James $70 → $65 Maintains Strong Buy
08/04/2022 -6.04% Barclays $80 → $63 Maintains Overweight
06/21/2022 11.86% Truist Securities $85 → $75 Maintains Buy
06/21/2022 10.37% Stephens & Co. $78 → $74 Maintains Overweight
06/17/2022 4.4% Raymond James $85 → $70 Maintains Strong Buy
06/10/2022 22.3% Credit Suisse $83 → $82 Maintains Outperform
06/08/2022 22.3% RBC Capital $85 → $82 Maintains Outperform
05/03/2022 26.77% RBC Capital $104 → $85 Maintains Outperform
05/02/2022 26.77% Raymond James $80 → $85 Maintains Strong Buy
04/29/2022 23.79% Credit Suisse $82 → $83 Maintains Outperform
02/07/2022 19.31% Raymond James $90 → $80 Maintains Strong Buy
11/03/2021 19.31% Mizuho $94 → $80 Maintains Buy
11/02/2021 34.23% Raymond James $107 → $90 Maintains Strong Buy
10/13/2021 31.25% Truist Securities $100 → $88 Maintains Buy
09/24/2021 46.16% UBS → $98 Initiates Coverage On → Buy
08/02/2021 59.58% Raymond James $95 → $107 Upgrades Outperform → Strong Buy
07/29/2021 55.11% RBC Capital $102 → $104 Maintains Outperform
07/29/2021 46.16% Credit Suisse $96 → $98 Maintains Outperform
07/02/2021 55.11% Deutsche Bank $87 → $104 Upgrades Hold → Buy
04/29/2021 41.69% Raymond James $90 → $95 Maintains Outperform
01/28/2021 37.21% Credit Suisse $97 → $92 Maintains Outperform
11/30/2020 34.23% Raymond James $78 → $90 Maintains Outperform
11/23/2020 43.18% Barclays → $96 Upgrades Equal-Weight → Overweight
11/02/2020 26.77% Credit Suisse $89 → $85 Maintains Outperform
11/02/2020 16.33% Raymond James $86 → $78 Maintains Outperform
07/27/2020 28.26% Jefferies $90 → $86 Maintains Buy
05/01/2020 34.23% UBS $96 → $90 Maintains Buy
04/30/2020 28.26% Raymond James $90 → $86 Maintains Outperform
03/06/2020 43.18% UBS $95 → $96 Maintains Buy
03/06/2020 23.79% Deutsche Bank $73 → $83 Maintains Hold
03/05/2020 49.14% Baird $85 → $100 Maintains Outperform
03/05/2020 34.23% Mizuho $87 → $90 Maintains Buy
03/05/2020 49.14% Stephens & Co. $91 → $100 Maintains Overweight
02/10/2020 29.75% Mizuho $84 → $87 Maintains Buy
02/10/2020 49.14% SunTrust Robinson Humphrey $90 → $100 Maintains Buy
01/15/2020 32.74% Credit Suisse $77 → $89 Maintains Outperform
01/14/2020 31.25% BMO Capital $85 → $88 Maintains Outperform
01/10/2020 29.75% UBS $80 → $87 Maintains Buy
12/11/2019 1.42% Wells Fargo → $68 Downgrades Equal-Weight → Underweight
09/17/2019 4.4% Deutsche Bank → $70 Initiates Coverage On → Hold
09/06/2019 — B of A Securities Upgrades Neutral → Buy
07/31/2019 11.86% Raymond James $80 → $75 Maintains Outperform
06/27/2019 7.38% BMO Capital → $72 Initiates Coverage On → Outperform
05/30/2019 4.4% Barclays $68 → $70 Upgrades Equal-Weight → Overweight
12/20/2018 — Jefferies Initiates Coverage On → Buy
12/14/2018 11.86% Barclays → $75 Initiates Coverage On → Equal-Weight
11/16/2018 28.26% UBS → $86 Initiates Coverage On → Buy

What is the target price for Encompass Health (EHC)?

There is no price target for Encompass Health

What is the most recent analyst rating for Encompass Health (EHC)?

There is no analyst for Encompass Health

When is the next analyst rating going to be posted or updated for Encompass Health (EHC)?

There is no next analyst rating for Encompass Health

Is the Analyst Rating Encompass Health (EHC) correct?

There is no next analyst rating for Encompass Health

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする